ENTITY
111 Inc

111 Inc (YI US)

121
Analysis
Information TechnologyChina
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription, and other services. 111 serves patients in China.
more
bullishChindata Group
10 Dec 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Perpetual, Weiqiao Textile,Tokyo Rakutenchi,Toyo, Chindata

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
416 Views
Share
bearishOrigin Energy
04 Dec 2023 00:11

Merger Arb Mondays (4 Dec) - Origin, OreCorp, Healius, CIMC Vehicles, T&K Toka, Eoflow, Hollysys

This week, the highest gross spreads are Eoflow (215.5%), 111 (93.7%), IRC (22.9%), OreCorp (20.8%), Healius (18.7%), Hollysys (15.5%), Origin...

Logo
1.1k Views
Share
03 Dec 2023 07:00

(Mostly) Asia-Pac Weekly Risk Arb Wrap: Glosel, CIMC, Orecorp, Tietto Mineral, Lansen Pharmaceutical

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
389 Views
Share
01 Dec 2023 08:51

(Mostly) Asia M&A, Nov 2023: Taisho Pharma, CIMC Vehicle, CMIC, Japan Best Rescue, Shidax

For the month of November, 16 new deals were discussed on Smartkarma with an overall deal size of ~US$13bn. The average premium for the new deals...

Logo
495 Views
Share
bearishOrigin Energy
27 Nov 2023 00:18

Merger Arb Mondays (27 Nov) - Origin, OreCorp, Healius, Taisho, JSR, Eoflow, Hollysys, Haitong Intl

This week, the highest gross spreads are Eoflow (218%), 111 (69.4%), Taisho Pharma (55.5%), Healius (48.0%), IRC (20.4%), Hollysys (12.8%), Origin...

Logo
590 Views
Share
x